Preclinical evaluation of EPHX2 inhibition as a novel treatment for inflammatory bowel disease.

PLoS One · 2019 · PMC6474586 · PMID 31002701

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

We also observed highly significant hits to a laser capture microdissection (LCM)-derived signature of colon epithelial cells from UC patients (N = 6) compared to normal subjects (N = 11), available from GeneLogic.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.